{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:49:56Z","timestamp":1790754596793,"version":"4.1.0"},"reference-count":83,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin intervent Radiol"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Biliary strictures have several etiologies that can broadly be classified into benign and malignant causes. The clinical presentation is variable with strictures identified incidentally on imaging or during the evaluation of routine laboratory abnormalities. Symptoms and cholangitis lead to imaging that can diagnose biliary strictures. The diagnosis and medical management of biliary strictures will be discussed in this article.<\/jats:p>","DOI":"10.1055\/s-0041-1731086","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T18:42:22Z","timestamp":1628620942000},"page":"255-262","source":"Crossref","is-referenced-by-count":14,"title":["Biliary Strictures: Etiologies and Medical Management"],"prefix":"10.1055","volume":"38","author":[{"given":"Terrance","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Boike","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MCG.0b013e3182745d9f","article-title":"Patients with obstructive jaundice and biliary stricture \u2009\u00b1\u2009mass lesion on imaging: prevalence of malignancy and potential role of EUS-FNA","volume":"47","author":"P Tummala","year":"2013","journal-title":"J Clin Gastroenterol"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1987.5.6.969","article-title":"Biliary tract obstruction secondary to cancer: management guidelines and selected literature review","volume":"5","author":"J J Lokich","year":"1987","journal-title":"J Clin Oncol"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.suc.2009.12.004","article-title":"Palliation in pancreatic cancer","volume":"90","author":"E J Kruse","year":"2010","journal-title":"Surg Clin North Am"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02712816","article-title":"Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage","volume":"7","author":"M Porta","year":"2005","journal-title":"Clin Transl Oncol"},{"issue":"S 04","key":"ref5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/annonc\/10.suppl_4.S82","article-title":"Vagaries of clinical presentation of pancreatic and biliary tract cancer","volume":"10","author":"I Modolell","year":"1999","journal-title":"Ann Oncol"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1007302","article-title":"Recent advances in the management of cholangiocarcinomas","volume":"14","author":"J N Vauthey","year":"1994","journal-title":"Semin Liver Dis"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"A Bergquist","year":"2002","journal-title":"J Hepatol"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"K M Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2147\/CEG.S195714","article-title":"Early diagnosis and management of malignant distal biliary obstruction: a review on current recommendations and guidelines","volume":"12","author":"M FY Viesca","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4251\/wjgo.v8.i6.498","article-title":"Malignant biliary obstruction: from palliation to treatment","volume":"8","author":"B R Boulay","year":"2016","journal-title":"World J Gastrointest Oncol"},{"issue":"26","key":"ref11","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.3748\/wjg.v13.i26.3531","article-title":"Endoscopic therapy of benign biliary strictures","volume":"13","author":"J R Judah","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12262-013-0972-7","article-title":"Surgical management of bile duct strictures","volume":"77","author":"M Kukar","year":"2015","journal-title":"Indian J Surg"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/ctr.12538","article-title":"Long-term follow-up of biliary complications after adult right-lobe living donor liver transplantation","volume":"29","author":"P TW Kim","year":"2015","journal-title":"Clin Transplant"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"W295","DOI":"10.2214\/AJR.10.6002","article-title":"Benign biliary strictures: a current comprehensive clinical and imaging review","volume":"197","author":"A KP Shanbhogue","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF01885126","article-title":"Bile duct strictures associated with hepatic arterial infusion chemotherapy","volume":"12","author":"R A Clark","year":"1987","journal-title":"Gastrointest Radiol"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain","volume":"21","author":"A Escorsell","year":"1994","journal-title":"J Hepatol"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis","volume":"332","author":"Y-M Lee","year":"1995","journal-title":"N Engl J Med"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000658-199101000-00004","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis","volume":"213","author":"C B Rosen","year":"1991","journal-title":"Ann Surg"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13651820701774883","article-title":"Biliary tract obstruction in chronic pancreatitis","volume":"9","author":"A A Abdallah","year":"2007","journal-title":"HPB (Oxford)"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archsurg.1984.01390170091018","article-title":"The spectrum of biliary tract obstruction from chronic pancreatitis","volume":"119","author":"G V Aranha","year":"1984","journal-title":"Arch Surg"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/bjs.1800690117","article-title":"Stenosis of the common bile duct in chronic pancreatitis","volume":"69","author":"F Wisl\u00f8off","year":"1982","journal-title":"Br J Surg"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s004640000046","article-title":"Endoscopic treatment of distal bile duct stricture from chronic pancreatitis","volume":"14","author":"G C Vitale","year":"2000","journal-title":"Surg Endosc"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MPA.0b013e3181bd64a1","article-title":"Clinical significance of extrapancreatic lesions in autoimmune pancreatitis","volume":"39","author":"I Naitoh","year":"2010","journal-title":"Pancreas"},{"issue":"07","key":"ref24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrgastro.2010.81","article-title":"Autoimmune pancreatitis and IgG4-related sclerosing disease","volume":"7","author":"T Kamisawa","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"906496","DOI":"10.1155\/2010\/906496","article-title":"Eosinophilic cholangitis and cholangiopathy: a sheep in wolves clothing","volume":"2010","author":"C Nashed","year":"2010","journal-title":"HPB Surg"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1023\/A:1018874612166","article-title":"Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the literature","volume":"42","author":"I Alam","year":"1997","journal-title":"Dig Dis Sci"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1056\/NEJM199601043340104","article-title":"Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee","volume":"334","author":"N B Vakil","year":"1996","journal-title":"N Engl J Med"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000016868","article-title":"Hepatobiliary diseases in patients with AIDS: focus on AIDS cholangiopathy and gallbladder disease","volume":"16","author":"C M Wilcox","year":"1998","journal-title":"Dig Dis"},{"issue":"07","key":"ref29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3748\/wjg.v24.i7.767","article-title":"Epidemiology, determinants, and management of AIDS cholangiopathy: a review","volume":"24","author":"M Naseer","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"08","key":"ref30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00002030-199508000-00007","article-title":"Diagnosis and prognosis of AIDS-related cholangitis","volume":"9","author":"M Ducreux","year":"1995","journal-title":"AIDS"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0002-9343(89)90381-1","article-title":"Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease","volume":"86","author":"J P Cello","year":"1989","journal-title":"Am J Med"},{"issue":"09","key":"ref32","first-page":"985","article-title":"Foamy macrophages in acquired immunodeficiency syndrome cholangiopathy with encephalitozoon intestinalis","volume":"121","author":"E Liberman","year":"1997","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/000313489906501009","article-title":"Current management of recurrent pyogenic cholangitis","volume":"65","author":"C A Cosenza","year":"1999","journal-title":"Am Surg"},{"issue":"05","key":"ref34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2214\/ajr.155.5.2120925","article-title":"Radiologic findings of clonorchiasis","volume":"155","author":"J H Lim","year":"1990","journal-title":"AJR Am J Roentgenol"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1148\/radiol.2202001252","article-title":"Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography","volume":"220","author":"M S Park","year":"2001","journal-title":"Radiology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bbadis.2017.06.013","article-title":"Post-transplant cholangiopathy: Classification, pathogenesis, and preventive strategies","volume":"1864","author":"Y de Vries","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"20","key":"ref37","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.3748\/wjg.v20.i20.6159","article-title":"Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation","volume":"20","author":"M M Mourad","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.surg.2009.06.052","article-title":"The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story","volume":"146","author":"A I Skaro","year":"2009","journal-title":"Surgery"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00535-003-1272-y","article-title":"Florid ischemic cholangitis due to leucocytoclastic vasculitis","volume":"39","author":"H U Kasper","year":"2004","journal-title":"J Gastroenterol"},{"issue":"26","key":"ref40","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJM199706263362607","article-title":"Imaging of the hepatobiliary tract","volume":"336","author":"S Saini","year":"1997","journal-title":"N Engl J Med"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2214\/ajr.168.4.9124155","article-title":"Cholangiocarcinoma at the hepatic hilus: sonographic findings","volume":"168","author":"L E Hann","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/jhep.2003.50232","article-title":"Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study","volume":"37","author":"B Condat","year":"2003","journal-title":"Hepatology"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.1840170510","article-title":"Biliary abnormalities associated with extrahepatic portal venous obstruction","volume":"17","author":"M S Khuroo","year":"1993","journal-title":"Hepatology"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrgastro.2015.182","article-title":"Evaluation of indeterminate biliary strictures","volume":"13","author":"C L Bowlus","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","article-title":"Bilirubin in clinical practice: a review","volume":"28","author":"J Fevery","year":"2008","journal-title":"Liver Int"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"P Y Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/qjmed\/hci004","article-title":"Contrasting liver function test patterns in obstructive jaundice due to biliary strictures [corrected] and stones","volume":"98","author":"J O Hayat","year":"2005","journal-title":"QJM"},{"issue":"09","key":"ref48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.7326\/0003-4819-110-9-704","article-title":"Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer","volume":"110","author":"D K Pleskow","year":"1989","journal-title":"Ann Intern Med"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archsurg.141.10.968","article-title":"Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions","volume":"141","author":"G \u0106wik","year":"2006","journal-title":"Arch Surg"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/1097-0142(19880515)61:10<2100::AID-CNCR2820611028>3.0.CO;2-Z","article-title":"CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases","volume":"61","author":"M Paganuzzi","year":"1988","journal-title":"Cancer"},{"issue":"02","key":"ref51","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence based appraisal","volume":"3","author":"U K Ballehaninna","year":"2012","journal-title":"J Gastrointest Oncol"},{"issue":"02","key":"ref52","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1158\/1078-0432.CCR-05-0564","article-title":"Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9","volume":"12","author":"J Koopmann","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ajg.2016.482","article-title":"A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study","volume":"112","author":"S Kaur","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1067\/mge.2002.125105","article-title":"Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"56","author":"E Siqueira","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"03","key":"ref55","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0016-5085(95)90462-X","article-title":"Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"108","author":"J K Ramage","year":"1995","journal-title":"Gastroenterology"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cld.2004.12.006","article-title":"Screening tests for hepatocellular carcinoma","volume":"9","author":"J A Marrero","year":"2005","journal-title":"Clin Liver Dis"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","article-title":"Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis","volume":"28","author":"B Liu","year":"2008","journal-title":"Liver Int"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"G Paumgartner","year":"2002","journal-title":"Hepatology"},{"issue":"08","key":"ref59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2036.2011.04822.x","article-title":"Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis","volume":"34","author":"C K Triantos","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"E Wunsch","year":"2014","journal-title":"Hepatology"},{"issue":"03","key":"ref61","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.27180","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?)","volume":"60","author":"J H Tabibian","year":"2014","journal-title":"Hepatology"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"K D Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"R Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"P Fickert","year":"2017","journal-title":"J Hepatol"},{"issue":"08","key":"ref65","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0002-9270(00)01059-5","article-title":"Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study","volume":"95","author":"H J van Hoogstraten","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","article-title":"A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis","volume":"106","author":"T A Knox","year":"1994","journal-title":"Gastroenterology"},{"issue":"03","key":"ref67","first-page":"455","article-title":"Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial","volume":"90","author":"D H Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis","volume":"27","author":"J A Talwalkar","year":"2007","journal-title":"Liver Int"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.12232","article-title":"Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study","volume":"37","author":"J H Tabibian","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"M F\u00e4rkkil\u00e4","year":"2004","journal-title":"Hepatology"},{"issue":"12","key":"ref71","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/lt.21201","article-title":"Classification and prognosis of intrahepatic biliary stricture after liver transplantation","volume":"13","author":"H W Lee","year":"2007","journal-title":"Liver Transpl"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"A Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cgh.2016.12.038","article-title":"Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis","volume":"15","author":"A Tanaka","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"09","key":"ref74","doi-asserted-by":"crossref","first-page":"e0183844","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients","volume":"12","author":"M Ebbo","year":"2017","journal-title":"PLoS One"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"M N Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"e9691","DOI":"10.1097\/MD.0000000000009691","article-title":"Current trends in the management of Mirizzi syndrome: a review of literature","volume":"97","author":"H Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"45","key":"ref77","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.3748\/wjg.v22.i45.9909","article-title":"Therapeutic approaches for portal biliopathy: a systematic review","volume":"22","author":"I Franceschet","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.31411","article-title":"Management of symptomatic portal cavernoma cholangiopathy with transplenic portal vein recanalization and transjugular intrahepatic portosystemic shunt","volume":"73","author":"A Abud","year":"2021","journal-title":"Hepatology"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9343(00)00318-1","article-title":"Ursodeoxycholic acid therapy in hepatobiliary disease","volume":"108","author":"K V Kowdley","year":"2000","journal-title":"Am J Med"},{"issue":"04","key":"ref80","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0016-5107(93)70164-9","article-title":"Treatment of non-extractable common bile duct stones with combination ursodeoxycholic acid plus endoprostheses","volume":"39","author":"G K Johnson","year":"1993","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.hbpd.2018.01.008","article-title":"Pathophysiological consequences of obstructive jaundice and perioperative management","volume":"17","author":"E T Pavlidis","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"03","key":"ref82","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archsurg.139.3.299","article-title":"Factors predicting advanced hepatic fibrosis in patients with postcholecystectomy bile duct strictures","volume":"139","author":"S S Negi","year":"2004","journal-title":"Arch Surg"},{"issue":"02","key":"ref83","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02236664","article-title":"Hepatic cirrhosis secondary to obstruction of the biliary system","volume":"10","author":"B A Scobie","year":"1965","journal-title":"Am J Dig Dis"}],"container-title":["Seminars in Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1731086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T21:25:21Z","timestamp":1673040321000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1731086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":83,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,8,10]]},"published-print":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1731086","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0739-9529","1098-8963"],"issn-type":[{"value":"0739-9529","type":"print"},{"value":"1098-8963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}